[AIDS-related early mortality in Mexico between 2008 and 2012]
Related Experiment Video
Updated: Mar 30, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Omar Silverman-Retana1, Sergio Bautista-Arredondo1, Edson Serván-Mori1
1Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Objective:
To describe the distribution of AIDS-related mortality according to the time of occurrence since entry to the System for the Administration, Logistics and Surveillance of Antiretrovirals (SALVAR, in Spanish), among users of Ministry of Health facilities in Mexico.
Materials And Methods:
Descriptive analysis of AIDS mortality and the related clinical and demographic profile of 41847 patients registered in SALVAR.
Results:
3195 patients (8.1%) died within the study period, 59% of these deaths occurred within six months after treatment initiation. Among those patients, 87.3% were diagnosed late, given their CD4 levels (CD4cel<200 cel/ml³).
Conclusion:
Our results underscore the need to strengthen programs aimed to increase opportune HIV diagnosis and linkage to care, as a key component of universal access policy to antiretroviral treatment in Mexico.
Insights
Most AIDS deaths in Mexico occur within six months of starting antiretroviral treatment, often due to late HIV diagnosis. Strengthening early diagnosis and care linkage is crucial for effective HIV treatment access.
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Background:
- Access to antiretroviral treatment (ART) is a cornerstone of HIV/AIDS management.
- Understanding mortality patterns post-ART initiation is vital for optimizing care.
- The System for the Administration, Logistics and Surveillance of Antiretrovirals (SALVAR) in Mexico provides a data source for such analyses.
Purpose of the Study:
- To analyze the timing of AIDS-related mortality among patients accessing Ministry of Health facilities in Mexico.
- To identify factors associated with early mortality after ART initiation.
Main Methods:
- A descriptive analysis was conducted on a cohort of 41,847 patients registered in SALVAR.
- AIDS mortality data and associated clinical/demographic profiles were examined.
- Time-to-death analysis relative to ART initiation was performed.
Main Results:
- A total of 3,195 patients (8.1%) died during the study period.
- Over half (59%) of these deaths occurred within six months of ART initiation.
- Late HIV diagnosis (CD4 count <200 cells/mL) was prevalent in 87.3% of early mortality cases.
Conclusions:
- A significant proportion of AIDS-related deaths occur early in the course of ART.
- Late HIV diagnosis is a major contributing factor to early mortality.
- Enhanced HIV diagnosis and timely linkage to care are critical for improving outcomes and achieving universal ART access in Mexico.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Cytomegalovirus Disease

